1. High Mortality of HLH in ICU Regardless Etiology or Treatment
- Author
-
Amandine Bichon, Jérémy Bourenne, Jérôme Allardet-Servent, Laurent Papazian, Sami Hraiech, Christophe Guervilly, Vanessa Pauly, Gilles Kaplanski, Djamel Mokart, Marc Gainnier, and Julien Carvelli
- Subjects
medicine.medical_specialty ,Medicine (General) ,endocrine system ,intensive care unit ,law.invention ,R5-920 ,law ,Internal medicine ,hemic and lymphatic diseases ,medicine ,Original Research ,Hemophagocytic lymphohistiocytosis ,hemophagocytosis ,business.industry ,Mortality rate ,fungi ,Retrospective cohort study ,General Medicine ,medicine.disease ,musculoskeletal system ,Intensive care unit ,hemophagocytic lymphohistiocytosis ,Macrophage activation syndrome ,cytokine storm ,Etiology ,Medicine ,SOFA score ,Hemophagocytosis ,business ,hormones, hormone substitutes, and hormone antagonists ,macrophage activation syndrome - Abstract
Background: Adult hemophagocytic lymphohistiocytosis (HLH) is highly lethal in the ICU. The diagnostic and therapeutic emergency that HLH represents is compounded by its unknown pathophysiological mechanisms. Here, we report on a large cohort of adult HLH in the ICU (ICU-HLH). We analyzed prognostic factors associated with mortality to define the diagnostic and therapeutic challenges in this specific population.Methods: This retrospective study included adult patients diagnosed with HLH in four ICUs in Marseille, France between 2010 and 2020. Patients who fulfilled the HLH-2004 criteria (≥ 4/8) and/or had an HScore ≥ 169 were diagnosed with HLH. HLH was categorized into four groups according to etiology: sepsis-associated HLH, intracellular infection-associated HLH, malignancy-associated HLH, and idiopathic HLH.Results: Two hundred and sixty patients were included: 121 sepsis-associated HLH (47%), 84 intracellular infection-associated HLH (32%), 28 malignancy-associated HLH (11%), and 27 idiopathic HLH (10%). The ICU mortality rate reached 57% (n = 147/260) without a statistical difference between etiological groups. Independent factors associated with mortality in multivariate analysis included age (OR (5 years) = 1.31 [1.16–1.48], p < 0.0001), SOFA score at ICU admission (OR = 1.37 [1.21–1.56], p < 0.0001), degradation of the SOFA score between ICU arrival and HLH diagnosis (Delta SOFA) (OR = 1.47 [1.28–1.70], p < 0.0001), the presence of bone-marrow hemophagocytosis (OR = 5.27 [1.11–24.97], p = 0.04), highly severe anemia (OR = 1.44 [1.09–1.91], p = 0.01), and hypofibrinogenemia (OR = 1.21 [1.04–1.41], p = 0.02).Conclusions: In this large retrospective cohort study of critically ill patients, ICU-HLH in adults was associated with a 57% mortality rate, regardless of HLH etiology or specific treatment. Factors independently associated with prognosis included age, presence of hemophagocytosis in bone-marrow aspirates, organ failure at admission, and worsening organ failure during the ICU stay. Whether a rapid diagnosis and the efficacy of specific therapy improve outcome is yet to be prospectively investigated.
- Published
- 2021